Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3626
Melco Resorts & Entertainment
MLCO
$1.5B
| $137K | ﹤0.01% |
25,955
-5,597
| -18% | -$31.3K |
2017 Q2
36 quarters
|
|
3627
Forward Industries Inc
FWDI
$484M
| $136K | ﹤0.01% |
+32,278
| New | +$144K |
2026 Q2
0 quarters
|
|
|
ABTC
3628
American Bitcoin Corp
ABTC
$484M
| $134K | ﹤0.01% |
13,165
+3,176
| +32% | +$48.6K |
2025 Q3
3 quarters
|
|
3629
Security National Financial
SNFCA
$240M
| $134K | ﹤0.01% |
14,574
-3,447
| -19% | -$31.5K |
2025 Q2
4 quarters
|
|
3630
DELISTED
GETTY IMAGES HLDGS INC A
GETY
| $134K | ﹤0.01% |
155,453
-103,702
| -40% | -$89.8K |
2024 Q2
8 quarters
|
|
3631
Xponential Fitness
XPOF
$188M
| $133K | ﹤0.01% |
+19,237
| New | +$122K |
2026 Q2
0 quarters
|
|
3632
enCore Energy
EU
$138M
| $133K | ﹤0.01% |
101,434
-49,758
| -33% | -$83.7K |
2023 Q2
12 quarters
|
|
3633
Priority Technology Holdings
PRTH
$647M
| $133K | ﹤0.01% |
19,907
+6,806
| +52% | +$39.4K |
2025 Q4
2 quarters
|
|
3634
Liberty Latin America Class A
LILA
$1.65B
| $132K | ﹤0.01% |
16,890
-11,233
| -40% | -$62.6K |
2019 Q1
29 quarters
|
|
3635
Blue Ridge Bankshares
BRBS
$352M
| $132K | ﹤0.01% |
37,297
-726
| -2% | -$2.53K |
2025 Q2
4 quarters
|
|
3636
Lineage Cell Therapeutics
LCTX
$253M
| $131K | ﹤0.01% |
+100,129
| New | +$138K |
2026 Q2
0 quarters
|
|
3637
908 Devices
MASS
$465M
| $130K | ﹤0.01% |
14,960
+832
| +6% | +$6.39K |
2025 Q1
5 quarters
|
|
3638
Korea Electric Power
KEP
$13.3B
| $130K | ﹤0.01% |
+10,718
| New | +$148K |
2026 Q2
0 quarters
|
|
3639
Inhibikase Therapeutics
IKT
$233M
| $126K | ﹤0.01% |
62,103
+27,746
| +81% | +$49.7K |
2025 Q2
4 quarters
|
|
3640
Sidus Space
SIDU
$117M
| $126K | ﹤0.01% |
+44,778
| New | +$172K |
2026 Q2
0 quarters
|
|
3641
NovaBridge Biosciences American Depositary Shares
NBP
$140M
| $123K | ﹤0.01% |
62,885
+34,724
| +123% | +$70.8K |
2025 Q4
2 quarters
|
|
3642
Kingsway Corp
KWY
$284M
| $122K | ﹤0.01% |
11,681
-6,534
| -36% | -$70.5K |
2025 Q3
3 quarters
|
|
3643
DELISTED
Leslie's
LESL
| $121K | ﹤0.01% |
11,951
-13,468
| -53% | -$52.8K |
2020 Q4
22 quarters
|
|
3644
Pliant Therapeutics
PLRX
$53.3M
| $119K | ﹤0.01% |
104,678
-10,540
| -9% | -$12.8K |
2023 Q2
12 quarters
|
|
3645
Quantum Corp
QMCO
$720M
| $119K | ﹤0.01% |
+10,839
| New | +$104K |
2026 Q2
0 quarters
|
|
3646
Galectin Therapeutics
GALT
$335M
| $119K | ﹤0.01% |
25,692
+1,899
| +8% | +$4.92K |
2025 Q4
2 quarters
|
|
3647
Oramed Pharmaceuticals
ORMP
$176M
| $119K | ﹤0.01% |
+24,751
| New | +$98.5K |
2026 Q2
0 quarters
|
|
3648
Sky Harbour Group
SKYH
$391M
| $119K | ﹤0.01% |
+12,056
| New | +$118K |
2026 Q2
0 quarters
|
|
3649
Journey Medical
DERM
$153M
| $118K | ﹤0.01% |
16,679
-1,817
| -10% | -$10.4K |
2025 Q4
2 quarters
|
|
3650
Equillium
EQ
$111M
| $116K | ﹤0.01% |
+36,291
| New | +$87K |
2026 Q2
0 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.